Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Glioblastoma 4Glioma 3Brain Neoplasms 3Neuroblastoma 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Spinal Cord Neoplasms 1Sarcoma 1Paraganglioma, Extra-Adrenal 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neurofibroma 1Neoplasms 1Meningioma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1

Interventions

Carboplatin 5Filgrastim 4Thiotepa 3Temozolomide 3Radiotherapy 3Cyclophosphamide 3sargramostim 2fludarabine 2aldesleukin 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Busulfan 2sodium thiosulfate 1pembrolizumab 1ixabepilone 1fludarabine phosphate 1etoposide phosphate 1erythromycin propionate-N-acetylcysteinate 1brodalumab 1Topotecan 1Thrombopoietin 1Tamoxifen 1Stem Cell Transplantation 1Sevoflurane 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Restraint, Physical × CNS × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡